{
"CYTK": "FDA Pushes Potential Approval For Cytokinetics' Experimental Heart Drug By Three Months",
"IRTC": "Strong Revenue Growth Amidst Beat Expectations",
"MSTR": "Investors Are Piling Into This Hot New SPAC Stock",
"WLK": "Q1 2025 Earnings Call Highlights: Navigating Challenges",
"COMM": "Strong Growth Amid Economic",
"O": "Market-Beating Potential",
"LUMN": "Q1 Loss Narrower Than Expected, Revenues Fall Y/Y",
"KO": "Impervious to the Stock Market Sell-Off",
"SOUN": "Stock Drops Despite Market Gains: Important Facts to Note",
"PLTR": "Prediction: This Super Software Growth Stock Will Be Worth More",
"VIAV": "Third Quarter Earnings: Beats Expectations",
"HL": "Record Revenue and Strategic Growth Plans",
"SBUX": "Turnaround Strategy",
"HOOD": "Taking a Look at Key Metrics Versus Estimates"
}